LONDON, UK — 4th March 2024, Access Infinity, an award-winning market access consultancy and digital solutions firm, today announced it has acquired some of the engineering team of its long-term partner Incepteo, previously responsible for supporting the build of innovative products for Access Infinity. This move follows a strategic transfer agreement with Incepteo, and positions Access Infinity for accelerated growth and enhanced in-house development capabilities.
Also commenting on the acquisition, Founding Director, Shri Rao Mukku said:
The acquired team boasts highly skilled architects, developers, and testers who have played a crucial role in developing Access Infinity’s innovative products. The addition of this talent pool represents a significant milestone in the company’s trajectory, allowing the company to bolster its in-house engineering capabilities to create and deliver industry-leading solutions, propel expansion efforts and foster greater agility and efficiency.
About Access Infinity
Access Infinity exists to help pharma companies overcome market access challenges. Founded in 2014, the company began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies and continues to be a leader in the space. It has since introduced market-redefining digital tools, NUROTM, Access HubTM and Evidence Library to help market access teams work smarter, faster, and more efficiently with valuable insights at their fingertips.
With offices in London, Hyderabad and Manchester, Access Infinity is experiencing rapid growth as it continues to transform and simplify market access for pharmaceutical organisations globally. Clients include many of the pharmaceutical industry’s leading companies such as Astra Zeneca, GSK and Pfizer. In 2023 Access Infinity received a Bronze Stevie® Award in the Technical Innovation of the Year category for organisations with up to 100 employees. The business was also recognised in GHP magazine’s Healthcare & Pharmaceutical Awards, winning “Most innovative digital pharmaceuticals platform 2023 UK”.
Email: louise@accessinfinity.com